Real-time enrollment status for this ischemic stroke clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 11:11 AM UTC
| NCT Number | NCT05948566 |
| Recruiting Status | Recruiting |
| Condition | Ischemic Stroke |
| Phase | PHASE2 |
| Target Enrollment | 300 participants |
| Active Locations | 52 sites in the US |
| Sponsor | Translational Sciences, Inc. |
| Last Updated on CT.gov | June 2, 2026 (Jun 2, 2026) |
As of July 18, 2026: Clinical trial NCT05948566 is currently recruiting participants. This phase2 study for ischemic stroke is actively seeking new participants at 52 locations across the United States. The study is sponsored by Translational Sciences, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05948566 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 52 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05948566 was last updated Jun 2, 2026 (June 2, 2026). HelloStudys verifies this status automatically.